Showing results (181-190 of 831) with videos related to

Sort By:
Pageof 84
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1993
Association of anticholinergic activity of prescribed medications with postoperative deliriumL Tune, S Carr, T Cooper, et al.
Journal of Health Economics and Outcomes Research|September 23, 2024
Economic Evaluation of a Novel Treatment of Attention-Deficit/Hyperactivity Disorder in US Motor Vehicle DriversJacie T Cooper, John E Schneider, Jim Potenziano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2013
Local approaches to hereditary breast cancerB T Cooper, J O Murphy, V Sacchini, et al.
Journal of Cardiovascular Pharmacology|January 9, 2009
Sera from patients with diabetes do not alter the effect of mammalian target of rapamycin inhibition on smooth muscle cell proliferationStephanie C Moss, Daniel Lightell, Richard E Deichmann, et al.
Cureus|June 7, 2024
The Clinical and Histological Intersection of Cardiac Sarcoidosis and Giant Cell MyocarditisToishi Sharma, Kramer Wahlberg, Friederike Keating, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|December 19, 2017
Patient-Related Risk Factors for Periprosthetic Ankle Joint Infection: An Analysis of 6977 Total Ankle ArthroplastiesAlyssa Althoff, Jourdan M Cancienne, Minton T Cooper, et al.
Scientific Reports|August 1, 2018
Decreased signalling of EphA4 improves functional performance and motor neuron survival in the SOD1<sup>G93A</sup> ALS mouse modelJ Zhao, L T Cooper, A W Boyd, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
The molecular biology of the sperm surface. Post-testicular membrane remodellingC Kirchhoff, I Pera, P Derr, et al.
Clinical Chemistry|February 1, 1982
A candidate reference method for uric acid in serum. I. Optimization and evaluationP H Duncan, N Gochman, T Cooper, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2006
Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidenceB T Cooper, W Chapman, C S Neumann, et al.
Pageof 84